Abstract 603 Table 1

Patient Characteristics

Panel A. At baseline (Number of patients = 1631)
Characteristic Number of Patients (%) or Mean (SD)
Female sex 1446 (88.7%)
Age at diagnosis, years 34.5 (13.3)
Ethnicity
 White, North American 509 (31.2%)
 White, other 289 (17.7%)
 Black 268 (16.4%)
 Hispanic 258 (15.8%)
 Asian 250 (15.3%)
 Other 57 (3.5%)
Disease duration at baseline, months 5.6 (4.2)
Panel B. Follow-up (Number of assessments = 12,281)
Disease Activity State Number of Annual Assessments, (%) Number of Patients,* (%)
Remission Off-Treatment 2566 (20.8%) 612 (37.5%)
Remission On-Treatment 2421 (19.7%) 771 (47.3%)
LDA-TC 556 (4.5%) 277 (17.0%)
mLLDAS 680 (5.5%) 430 (26.4%)
Active 6058 (49.3%) 1446 (88.7%)
  • *The number of patients exceeds 1631 as a single patient may have multiple disease activity states during the study and will contribute assessments to multiple states.

  • LDA-TC: Low Disease Activity-Toronto Cohort; mLLDAS: Modified Lupus Low Disease Activity State